Xie H Erin 4
4 · BlackRock Health Sciences Term Trust · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Xie H Erin
Other
Transactions
- Disposition to Issuer
Common Stock
2025-01-31$16.49/sh−14,882.597$245,414→ 0 total - Exercise/Conversion
Phantom Shares
2025-01-31−7,835.651→ 15,671.302 total→ Common Stock (7,835.651 underlying) - Award
Phantom Shares
2025-01-31$16.49/sh+23,649.656$389,983→ 23,649.656 total→ Common Stock (23,649.656 underlying) - Exercise/Conversion
Common Stock
2025-01-31+14,882.597→ 14,882.597 total - Exercise/Conversion
Phantom Shares
2025-01-31−7,046.946→ 7,046.946 total→ Common Stock (7,046.946 underlying)
Footnotes (4)
- [F1]A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
- [F2]As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F3]As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F4]These phantom shares vest in equal installments on each of the first three anniversaries of the award.